Global Retirement Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Global Retirement Partners’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.04K	Buy	+71	New	+$3.39K	﹤0.01%	3761
2025 Q4	$3.2K	Sell	70 -70	-50%	-$3.1K	﹤0.01%	3576
2025 Q3	$5.46K	Buy	140 +70	+100%	+$2.54K	﹤0.01%	2944
2025 Q2	$2.37K	Buy	+70	New	+$2.22K	﹤0.01%	3182
2024 Q4	$2.73K	Buy	+70	New	+$2.94K	﹤0.01%	2958

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Global Retirement Partners's GNOM Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 71 shares worth $4.04K. The stake represents ﹤0.01% of the portfolio and ranks #3761 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in GNOM as recently as Q4 2025.

Global Retirement Partners first reported a position in GNOM in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.46K in Q3 2025. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Global Retirement Partners held 71 shares of Global X Genomics & Biotechnology ETF worth $4.04K as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new Global Retirement Partners position in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3761 holding.
Global Retirement Partners first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and has held it in 5 quarters since.
Global Retirement Partners's Global X Genomics & Biotechnology ETF position peaked at $5.46K in Q3 2025.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.